Celanese Advances Deleveraging Through Nutrinova Sale to Mitsui

Zacks
Öffnen unter Zacks
Celanese Advances Deleveraging Through Nutrinova Sale to Mitsui

Celanese Corporation CE continues to advance the portfolio optimization and debt-reduction efforts with the completion of the sale of an additional 19% stake in its Nutrinova food ingredients joint venture to Mitsui & Co., Ltd. This transaction generated $152 million in cash proceeds, marking another step toward the company's target of securing $1 billion in divestiture proceeds by the end of 2027.

The divestiture is an attractive realization of value for Celanese, monetizing an ownership interest that contributed approximately $4 million in equity earnings in 2025. However, the company will retain an 11% stake in the joint venture, allowing it to maintain some participation in Nutrinova's food ingredients business.

Celanese plans to utilize these proceeds toward continued deleveraging, reinforcing its focus on strengthening the financial position and reducing debt. The transaction also reflects the company's ongoing efforts to streamline its portfolio.

Celanese has agreed to temporarily own and operate a diketene facility at its Frankfurt, Germany, chemical park to ensure raw material supply continuity for the joint venture before transferring the facility to Nutrinova. All associated ownership and operating costs, including the purchase price, will be borne by Nutrinova.

CE's shares have gained 39.2% in the past year compared with the industry’s 21.4% growth. 

Zacks Investment Research
Image Source: Zacks Investment Research

CE’s Zacks Rank & Key Picks

CE currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the Basic Materials space are Reliance, Inc. RS, Element Solutions Inc. ESI and Worthington Steel, Inc. WS.

RS currently sports a Zacks Rank #1 (Strong Buy), while ESI and WS carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $26.54 per share, indicating an 86.1% year-over-year surge. RS’shares have gained 60.4% over the past year.

The Zacks Consensus Estimate for ESI’s 2026 earnings is pegged at $1.85 per share, indicating a year-over-year rise of 24.2%. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 6%.

The Zacks Consensus Estimate for WS’ current fiscal-year earnings is pinned at $4.07 per share. WS’shares have gained 24% over the past year.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Celanese Corporation (CE): Free Stock Analysis Report
 
Element Solutions Inc. (ESI): Free Stock Analysis Report
 
Reliance, Inc. (RS): Free Stock Analysis Report
 
Worthington Steel, Inc. (WS): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research